Search hospitals > Tennessee > Chattanooga
Chattanooga Oncology Hematology Associates
Claim this profileChattanooga, Tennessee 37404
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lymphoma
Conducts research for Cancer
129 reported clinical trials
6 medical researchers
Summary
Chattanooga Oncology Hematology Associates is a medical facility located in Chattanooga, Tennessee. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Lymphoma, Cancer and other specialties. Chattanooga Oncology Hematology Associates is involved with conducting 129 clinical trials across 64 conditions. There are 6 research doctors associated with this hospital, such as Meredith A McKean, Vijay Patel, Brooke Daniel, M.D., and Edward Arrowsmith.Area of expertise
1Lung Cancer
Global LeaderStage III
Stage IV
PD-L1 positive
2Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
Top PIs
Meredith A McKeanSarah Cannon Research Institute1 year of reported clinical research
Expert in Solid Tumors
Expert in Tumors
34 reported clinical trials
66 drugs studied
Vijay PatelFlorida Cancer Specialists4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
36 drugs studied
Brooke Daniel, M.D.Tennessee Oncology - Chattanooga Oncology & Hematology Associates1 year of reported clinical research
Studies Breast Cancer
Studies PD-L1 Negative
9 reported clinical trials
16 drugs studied
Edward ArrowsmithSCRI - Tennessee Oncology Chattanooga4 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
5 reported clinical trials
13 drugs studied
Clinical Trials running at Chattanooga Oncology Hematology Associates
Lymphoma
Prostate Cancer
Plasma Cell Neoplasms
Multiple Myeloma
Leukemia
Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Chronic B-Cell Leukemia
Preleukemia
Anemia
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Chattanooga Oncology Hematology Associates?
Chattanooga Oncology Hematology Associates is a medical facility located in Chattanooga, Tennessee. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Lymphoma, Cancer and other specialties. Chattanooga Oncology Hematology Associates is involved with conducting 129 clinical trials across 64 conditions. There are 6 research doctors associated with this hospital, such as Meredith A McKean, Vijay Patel, Brooke Daniel, M.D., and Edward Arrowsmith.